Historical data shows that a consistent $500 monthly investment into Palvella Therapeutics, Inc. (PVLA) starting in 2020 would have turned a total investment of $19K into $93K today. This represents a total return of 391.4% over the 6-year period, compounding through dividend reinvestment and market growth.
The Impact of Dividend Reinvestment (DRIP)
Palvella Therapeutics, Inc. does not currently pay a notable dividend. For growth-focused stocks like PVLA, dollar cost averaging relies entirely on price appreciation. Over the 6-year period, the strategy successfully captured the stock's price movements, resulting in a final portfolio value of $93K without the need for dividend reinvestment.
PVLA vs. S&P 500 (SPY) Benchmark
When comparing this dollar cost averaging strategy against a broad market index,PVLA outperformed the S&P 500 ETF (SPY). The same $500 monthly contributions into SPY would have grown to $23K, compared to PVLA's $93K.